The patient is a 60-year-old resident of Russia’s Kursk region who received the first dose of the “Neoonkovak” vaccine in April.
First Melanoma Patient About to Complete Course of Russian Personalized Cancer Vaccine
RELATED ARTICLES
The patient is a 60-year-old resident of Russia’s Kursk region who received the first dose of the “Neoonkovak” vaccine in April.
